Cited by 2,049MicroRNA in disease regulationCancer-related molecular mechanisms researchCancer-related Molecular Pathways

The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.

MicroRNAs in cancer: biomarkers, functions and therapy

Open access

Hayes, Josie, Peruzzi, Pier Paolo, Lawler, Sean·2014·Trends in Molecular Medicine

DOI 10.1016/j.molmed.2014.06.005

Open this paper in CoChat — free account Open PDF

Abstract

The emergence of microRNAs has been one of the defining developments in cancer biology over the past decade, and the explosion of knowledge in this area has brought forward new diagnostic and therapeutic opportunities. The importance of microRNAs in cancer has been underlined by the identification of alterations in microRNA target binding sites and the microRNA processing machinery in tumor cells. Clinical trials utilizing microRNA profiling for patient prognosis and clinical response are now underway, and the first microRNA mimic entered the clinic for cancer therapy in 2013. In this article we review the potential applications of microRNAs for the clinical assessment of patient outcome in cancer, as well as in cancer monitoring and therapy.

Integrity signals

Registry

Crossref · 10.1016/j.molmed.2014.06.005

Cites

79 of 79 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

The text we found for this paper looks like another document, so its claims and self-check weren’t run. The registry and citation checks still apply.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The text we found for this paper looks like another document, so the self-check wasn’t run.

1 retracted

HMGA2 functions as a competing endogenous RNA to promote lung cancer progression
Kumar, M. S., Armenteros-Monterroso, E., East, P., Chakravorty, P., Matthews, N., Winslow, M. M., & Downward, J. (2013) · Nature · doi:10.1038/nature12785 · Cited by 255
Retracted
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14
Lee, R. C., Feinbaum, R. L., & Ambros, V. (1993) · Cell · doi:10.1016/0092-8674(93)90529-y · Cited by 12,948
MicroRNA expression profiles classify human cancers
Lü, J., Getz, G. A., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B. L., Mak, R. H., Ferrando, A. A., et al. (2005) · Nature · doi:10.1038/nature03702 · Cited by 9,637
Circular RNAs are a large class of animal RNAs with regulatory potency
Memczak, S., Jens, M., Elefsinioti, A., Torti, F., Krueger, J., Rybak, A., Maier, L., Mackowiak, S. D., Gregersen, L. H., Munschauer, M., et al. (2013) · Nature · doi:10.1038/nature11928 · Cited by 7,990
Circulating microRNAs as stable blood-based markers for cancer detection
Mitchell, P. S., Parkin, R. K., Kroh, E. M., Fritz, B. R., Wyman, S. K., Pogosova-Agadjanyan, E. L., Peterson, A., Noteboom, J., O'Briant, K. C., Allen, A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804549105 · Cited by 7,969
Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia
Calin, G. A., Dumitru, C. D., Shimizu, M., Bichi, R., Zupo, S., Noch, E., Aldler, H., Rattan, S., Keating, M., Rai, K., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242606799 · Cited by 5,111
The widespread regulation of microRNA biogenesis, function and decay
Krol, J., Loedige, I., & Filipowicz, W. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2843 · Cited by 4,672
miRBase: tools for microRNA genomics
Griffiths‐Jones, S., Saini, H. K., van Dongen, S., & Enright, A. J. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm952 · Cited by 4,432
Treatment of HCV Infection by Targeting MicroRNA
Janssen, H. L. A., Reesink, H. W., Lawitz, E., Zeuzem, S., Rodriguez‐Torres, M., Patel, K., van der Meer, A. J., Patick, A. K., Chen, A. P., Zhou, Y., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1209026 · Cited by 2,262

Flagged first, then by citations

Show all 79 references

Research works printed but not linked: 1

Choudhury, 2012, Attenuated adenosine-to-inosine editing of microRNA-376a* promotes invasiveness of glioblastoma cells, J. Clin. Invest., 122, 4059, 10.1172/JCI62925 · DOI

Sorted by citations

Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation
O'Brien, J., Hayder, H., Zayed, Y., & Peng, C. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00402 · Cited by 5,287
LncRNA-mediated regulation of cell signaling in cancer
Peng, W.-X., Koirala, P., & Mo, Y.-Y. (2017) · Oncogene · doi:10.1038/onc.2017.184 · Cited by 1,649
miRNAs as Biomarkers in Disease: Latest Findings Regarding Their Role in Diagnosis and Prognosis
Condrat, C. E., Thompson, D. C., Barbu, M. G., Bugnar, O. L., Boboc, A. E., Crețoiu, D., Suciu, N., Creţoiu, S. M., & Voinea, S. C. (2020) · Cells · doi:10.3390/cells9020276 · Cited by 1,399
An overview of microRNAs
Hammond, S. M. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.05.001 · Cited by 1,324
siRNA versus miRNA as therapeutics for gene silencing
Lam, J. K. W., Chow, M. Y. T., Zhang, Y., & Leung, S. W. S. (2015) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2015.23 · Cited by 1,081
Progress and prospects of early detection in lung cancer
Knight, S., Crosbie, P. A. J., Balata, H., Chudziak, J., Hussell, T., & Dive, C. (2017) · Open Biology · doi:10.1098/rsob.170070 · Cited by 964
Circular RNAs are miRNA sponges and can be used as a new class of biomarker
Kulcheski, F. R., Christoff, A. P., & Margis, R. (2016) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2016.09.011 · Cited by 741
Aptamer-Based Detection of Circulating Targets for Precision Medicine
Wu, L., Wang, Y., Xu, X., Liu, Y., Lin, B., Zhang, M., Zhang, J., Wan, S., Yang, C. J., & Tan, W. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c01140 · Cited by 706
A network-biology perspective of microRNA function and dysfunction in cancer
Bracken, C. P., Scott, H. S., & Goodall, G. J. (2016) · Nature Reviews Genetics · doi:10.1038/nrg.2016.134 · Cited by 688
MicroRNA (miRNA) in cancer
Reddy, K. B. (2015) · Cancer Cell International · doi:10.1186/s12935-015-0185-1 · Cited by 634
Recent advances in biosensor development for the detection of cancer biomarkers
Jayanthi, V. S. P. K. S. A., Das, A. B., & Saxena, U. (2016) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2016.12.014 · Cited by 569
Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer
Zhang, H., Dai, Z., Wu, W., Wang, Z., Zhang, N., Zhang, L., Zeng, W., Liu, Z., & Cheng, Q. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01987-7 · Cited by 551
N6-methyladenosine links RNA metabolism to cancer progression
Dai, D., Wang, H., Zhu, L., Jin, H., & Wang, X. (2018) · Cell Death and Disease · doi:10.1038/s41419-017-0129-x · Cited by 472
Data Normalization Strategies for MicroRNA Quantification
Schwarzenbach, H., da Silva, A. M., Calin, G., & Pantel, K. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2015.239459 · Cited by 468
MicroRNA in lung cancer: role, mechanisms, pathways and therapeutic relevance
Iqbal, M. A., Arora, S., Prakasam, G., Călin, G. A., & Syed, M. A. (2018) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.07.003 · Cited by 455
MicroRNA: A signature for cancer progression
Hussen, B. M., Hidayat, H. J., Salihi, A. B., Sabir, D. K., Taheri, M. N., & Ghafouri‐Fard, S. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111528 · Cited by 411
RNA Drugs and RNA Targets for Small Molecules: Principles, Progress, and Challenges
Yu, A., Choi, Y. H., & Tu, M. (2020) · Pharmacological Reviews · doi:10.1124/pr.120.019554 · Cited by 421
Stress granules, P-bodies and cancer
Anderson, P., Kedersha, N., & Ivanov, P. V. (2014) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.11.009 · Cited by 408
Trials and Tribulations of MicroRNA Therapeutics
Seyhan, A. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031469 · Cited by 381
Micro RNA s in metabolism
Vienberg, S. G., Geiger, J., Madsen, S., & Dalgaard, L. T. (2016) · Acta Physiologica · doi:10.1111/apha.12681 · Cited by 385
Mechanisms of neovascularization. Vascular sprouting can occur without proliferation of endothelial cells.
Sholley, M. M., Ferguson, G. P., Seibel, H. R., Montour, J. L., & Wilson, J. D. (1984) · PubMed · Cited by 332
RNAi-Based Therapeutics and Novel RNA Bioengineering Technologies
Traber, G. M., & Yu, A. (2022) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.122.001234 · Cited by 311
Role of miRNA-Regulated Cancer Stem Cells in the Pathogenesis of Human Malignancies
Khan, A. S., Ahmed, E. I., Elareer, N. R., Junejo, K., Steinhoff, M. S., & Shahab Uddin, M. S. (2019) · Cells · doi:10.3390/cells8080840 · Cited by 296
circHIPK3 regulates cell proliferation and migration by sponging miR-124 and regulating AQP3 expression in hepatocellular carcinoma
Chen, G., Shi, Y., Liu, M., & Sun, J. (2018) · Cell Death and Disease · doi:10.1038/s41419-017-0204-3 · Cited by 297
Noncoding RNAs in cancer therapy resistance and targeted drug development
Wang, W., Han, C., Sun, Y., Chen, T.-Q., & Chen, Y. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0748-z · Cited by 273
Emerging roles of lncRNAs in the post-transcriptional regulation in cancer
He, R., Luo, D., & Mo, Y. (2019) · Genes & Diseases · doi:10.1016/j.gendis.2019.01.003 · Cited by 258
MicroRNA-based therapeutics in central nervous system injuries
Sun, P., Liu, D. Z., Jickling, G. C., Sharp, F. R., & Yin, K.-J. (2018) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x18773871 · Cited by 228
Identification of non-invasive miRNAs biomarkers for prostate cancer by deep sequencing analysis of urinary exosomes
Rodríguez, M., Bajo-Santos, C., Hessvik, N. P., Lorenz, S., Fromm, B., Berge, V., Sandvig, K., Linē, A., & Llorente, A. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0726-4 · Cited by 255
Dependence of Intracellular and Exosomal microRNAs on Viral E6/E7 Oncogene Expression in HPV-positive Tumor Cells
Honegger, A., Schilling, D., Bastian, S., Sponagel, J., Kuryshev, V., Sültmann, H., Scheffner, M., Hoppe-Seyler, K., & Hoppe-Seyler, F. (2015) · PLOS Pathogens · doi:10.1371/journal.ppat.1004712 · Cited by 222
Challenges identifying efficacious miRNA therapeutics for cancer
Segal, M., & Slack, F. J. (2020) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2020.1765770 · Cited by 244
Multifaceted Role of Neuropilins in the Immune System: Potential Targets for Immunotherapy
Roy, S., Bag, A. K., Singh, R. K., Talmadge, J. E., Batra, S. K., & Datta, K. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01228 · Cited by 248
Overview upon miR-21 in lung cancer: focus on NSCLC
Bica, C., Cojocneanu, R., Magdo, L., Ráduly, L., Gulei, D., & Berindan‐Neagoe, I. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2877-x · Cited by 235
MicroRNA-141 suppresses prostate cancer stem cells and metastasis by targeting a cohort of pro-metastasis genes
Liu, C., Liu, R., Zhang, D., Deng, Q., Liu, B., Chao, H., Rycaj, K., Takata, Y., Lin, K., Lu, Y., et al. (2017) · Nature Communications · doi:10.1038/ncomms14270 · Cited by 232
MicroRNA in cancer therapy: breakthroughs and challenges in early clinical applications
Martino, M. T. D., Tagliaferri, P., & Tassone, P. (2025) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-025-03391-x · Cited by 242
Microglia secrete miR-146a-5p-containing exosomes to regulate neurogenesis in depression
Fan, C., Li, Y., Lan, T., Wang, W., Long, Y., & Yu, S. Y. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2021.11.006 · Cited by 227
Exosomal microRNAs derived from mesenchymal stem cells: cell-to-cell messages
Asgarpour, K., Shojaei, Z., Amiri, F., Ai, J., Mahjoubin‐Tehran, M., Ghasemi, F., Arefnezhad, R., Hamblin, M. R., & Mirzaei, H. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-00650-6 · Cited by 224
Lateral flow assays towards point-of-care cancer detection: A review of current progress and future trends
Mahmoudi, T., de la Guárdia, M., & Baradaran, B. (2020) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2020.115842 · Cited by 220
Integrative methods for analyzing big data in precision medicine
Gligorijević, V., Malod‐Dognin, N., & Pržulj, N. (2015) · PROTEOMICS · doi:10.1002/pmic.201500396 · Cited by 226
cGAS–STING and Cancer: Dichotomous Roles in Tumor Immunity and Development
Ng, K. W., Marshall, E. A., Bell, J. C., & Lam, W. L. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.07.013 · Cited by 219
Multiple functions of p27 in cell cycle, apoptosis, epigenetic modification and transcriptional regulation for the control of cell growth: A double-edged sword protein
Abbastabar, M., Kheyrollah, M., Azizian, K., Bagherlou, N., Tehrani, S. S., Maniati, M., & Karimian, A. (2018) · DNA repair · doi:10.1016/j.dnarep.2018.07.008 · Cited by 219
Single-cell sequencing of the small-RNA transcriptome
Faridani, O. R., Abdullayev, I., Hagemann-Jensen, M., Schell, J. P., Lanner, F., & Sandberg, R. (2016) · Nature Biotechnology · doi:10.1038/nbt.3701 · Cited by 212
CRISPR/Cas12a-Assisted Ligation-Initiated Loop-Mediated Isothermal Amplification (CAL-LAMP) for Highly Specific Detection of microRNAs
Zhang, M., Wang, H., Wang, H., Wang, F., & Li, Z. (2021) · Analytical Chemistry · doi:10.1021/acs.analchem.1c00686 · Cited by 210
Long non-coding RNA CASC2 suppresses malignancy in human gliomas by miR-21
Wang, P., Liu, Y., Yao, Y., Li, Z., Li, Z., Ma, J., & Xue, Y. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.11.011 · Cited by 211
Circular RNA circCCDC9 acts as a miR-6792-3p sponge to suppress the progression of gastric cancer through regulating CAV1 expression
Luo, Z., Rong, Z., Zhang, J., Zhu, Z., Yu, Z., Li, T., Fu, Z., Qiu, Z., & Huang, C. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01203-8 · Cited by 206
MicroRNAs: Key Regulators in the Central Nervous System and Their Implication in Neurological Diseases
Cao, D., Li, L., & Chan, W. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17060842 · Cited by 211
Circular RNAs: A novel type of non-coding RNA and their potential implications in antiviral immunity
Wang, M., Yu, F., Wu, W., Zhang, Y., Chang, W., Ponnusamy, M., Wang, K., & Li, P. (2017) · International Journal of Biological Sciences · doi:10.7150/ijbs.22531 · Cited by 208
Tumour-initiating cell-specific miR-1246 and miR-1290 expression converge to promote non-small cell lung cancer progression
Zhang, W. C., Chin, T. M., Yang, H. H., Nga, M. E., Lunny, D. P., Lim, E. K. H., Sun, L., Pang, Y. H., Leow, Y. N., Malusay, S. R. Y., et al. (2016) · Nature Communications · doi:10.1038/ncomms11702 · Cited by 202
Circulating miRNA analysis for cancer diagnostics and therapy
Valihrach, L., Androvic, P., & Kubista, M. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2019.10.002 · Cited by 201
Phosphatidylserine: A cancer cell targeting biomarker
Sharma, B., & Kanwar, S. S. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.08.012 · Cited by 207
Advanced liquid biopsy technologies for circulating biomarker detection
Soda, N., Rehm, B. H. A., Sonar, P. M., Nguyen, N., & Shiddiky, M. J. A. (2019) · Journal of Materials Chemistry B · doi:10.1039/c9tb01490j · Cited by 205
Long non-coding RNA-SNHG7 acts as a target of miR-34a to increase GALNT7 level and regulate PI3K/Akt/mTOR pathway in colorectal cancer progression
Li, Y., Zeng, C., Hu, J., Pan, Y., Shan, Y., Liu, B., & Li, J. (2018) · Journal of Hematology & Oncology · doi:10.1186/s13045-018-0632-2 · Cited by 198
MiRNAs: Biology, Biogenesis, their Web-based Tools, and Databases
Tafrihi, M., & Hasheminasabgorji, E. (2018) · MicroRNA · doi:10.2174/2211536607666180827111633 · Cited by 198
CRISPR/Cas12a-based photoelectrochemical sensing of microRNA on reduced graphene oxide-anchored Bi2WO6 coupling with catalytic hairpin assembly
Gong, H., Hu, X., Zeng, R., Li, Y., Xu, J., Li, M., & Tang, D. (2022) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2022.132307 · Cited by 196
Autophagy: A novel mechanism of chemoresistance in cancers
Li, X., Zhou, Y., Li, Y., Yang, L., Ma, Y., Peng, X., Yang, S., Liu, J., & Li, H. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109415 · Cited by 200
Piwi-interacting RNAs in cancer: emerging functions and clinical utility
Ng, K. W., Anderson, C., Marshall, E. A., Minatel, B. C., Enfield, K. S. S., Saprunoff, H., Lam, W. L., & Martínez, V. D. (2016) · Molecular Cancer · doi:10.1186/s12943-016-0491-9 · Cited by 199
Circulating Cell-Free Nucleic Acids: Main Characteristics and Clinical Application
Szilágyi, M., Pös, O., Márton, É., Buglyó, G., Soltész, B., Keserű, J. S., Penyige, A., Szemes, T., & Nagy, B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186827 · Cited by 201
Regulatory Mechanisms of Epigenetic miRNA Relationships in Human Cancer and Potential as Therapeutic Targets
Arif, K. M. T., Elliott, E. K., Haupt, L. M., & Griffiths, L. R. (2020) · Cancers · doi:10.3390/cancers12102922 · Cited by 201
microRNAs: New prognostic, diagnostic, and therapeutic biomarkers in cervical cancer
Nahand, J. S., Taghizadeh‐boroujeni, S., Karimzadeh, M. R., Borran, S., Pourhanifeh, M. H., Moghoofei, M., Bokharaei‐Salim, F., Karampoor, S., Jafari, A. H., Asemi, Z., et al. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28457 · Cited by 189
Dysregulation of Nrf2 in Hepatocellular Carcinoma: Role in Cancer Progression and Chemoresistance
Raghunath, A., Sundarraj, K., Arfuso, F., Sethi, G., & Perumal, E. (2018) · Cancers · doi:10.3390/cancers10120481 · Cited by 187
MicroRNAs as potential diagnostic and prognostic biomarkers in melanoma
Mirzaei, H., Gholamin, S., Shahidsales, S., Sahebkar, A., Jaafari, M. R., Mirzaei, H. R., Hassanian, S. M., & Avan, A. (2015) · European Journal of Cancer · doi:10.1016/j.ejca.2015.10.009 · Cited by 183
RETRACTED: Exosome-Derived miR-130a Activates Angiogenesis in Gastric Cancer by Targeting C-MYB in Vascular Endothelial Cells
Yang, H., Zhang, H., Ge, S., Ning, T., Bai, M., Li, J., Li, S., Sun, W., Deng, T., Zhang, L., et al. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.07.023 · Cited by 182
Retracted
Universal and Programmable Rolling Circle Amplification-CRISPR/Cas12a-Mediated Immobilization-Free Electrochemical Biosensor
Qing, M., Chen, S. L., Sun, Z., Fan, Y., Luo, H. Q., & Li, N. B. (2021) · Analytical Chemistry · doi:10.1021/acs.analchem.1c00805 · Cited by 182
MicroRNA-Seq Data Analysis Pipeline to Identify Blood Biomarkers for Alzheimer's Disease from Public Data
Satoh, J., Kino, Y., & Niida, S. (2015) · Biomarker Insights · doi:10.4137/bmi.s25132 · Cited by 181
sRNAbench and sRNAtoolbox 2019: intuitive fast small RNA profiling and differential expression
Aparicio‐Puerta, E., Lebrón, R., Rueda, A., Gómez‐Martín, C., Giannoukakos, S., Jáspez, D., Medina, J. M., Zubković, A., Jurak, I., Fromm, B., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz415 · Cited by 174
Cancer and Embolic Stroke of Undetermined Source
Navi, B. B., Kasner, S. E., Elkind, M. S. V., Cushman, M., Bang, O. Y., & DeAngelis, L. M. (2021) · Stroke · doi:10.1161/strokeaha.120.032002 · Cited by 177
Systems biology-based investigation of cooperating microRNAs as monotherapy or adjuvant therapy in cancer
Lai, X., Eberhardt, M., Schmitz, U., & Vera, J. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz638 · Cited by 170
miRNA dysregulation is an emerging modulator of genomic instability
Cardoso, A. P. F., Banerjee, M., Nail, A. N., Lykoudi, A., & States, J. C. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.05.004 · Cited by 173
Delivery of Anti-miRNA for Triple-Negative Breast Cancer Therapy Using RNA Nanoparticles Targeting Stem Cell Marker CD133
Yin, H., Xiong, G., Guo, S., Xu, C., Xu, R., Guo, P., & Shu, D. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.04.018 · Cited by 168
Age‐associated micro RNA expression in human peripheral blood is associated with all‐cause mortality and age‐related traits
Huan, T., Chen, G., Liu, C., Bhattacharya, A., Rong, J., Chen, B. H., Seshadri, S. S., Tanrıverdi, K., Freedman, J. E., Larson, M. G., et al. (2017) · Aging Cell · doi:10.1111/acel.12687 · Cited by 171
Decreased levels of serum exosomal miR‐638 predict poor prognosis in hepatocellular carcinoma
Shi, M., Jiang, Y., Yang, L., Yan, S., Wang, Y., & Lu, X. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26650 · Cited by 161
Plasma miR-21, miR-155, miR-10b, and Let-7a as the potential biomarkers for the monitoring of breast cancer patients
Khalighfard, S., Alizadeh, A. M., Irani, S., & Omranipour, R. (2018) · Scientific Reports · doi:10.1038/s41598-018-36321-3 · Cited by 162
MicroRNAs as potential biomarkers for the diagnosis of glioma: A systematic review and meta‐analysis
Zhou, Q., Liu, J., Quan, J., Liu, W., Tan, H., & Li, W. (2018) · Cancer Science · doi:10.1111/cas.13714 · Cited by 160
Recent trends in microRNA research into breast cancer with particular focus on the associations between microRNAs and intrinsic subtypes
Kurozumi, S., Yamaguchi, Y., Kurosumi, M., Ohira, M., Matsumoto, H., & Horiguchi, J. (2016) · Journal of Human Genetics · doi:10.1038/jhg.2016.89 · Cited by 159
Clinical significance of microRNAs in chronic and acute human leukemia
Yeh, C., Moles, R., & Nicot, C. (2016) · Molecular Cancer · doi:10.1186/s12943-016-0518-2 · Cited by 154
Mutual regulation of microRNAs and DNA methylation in human cancers
Wang, S., Wu, W., & Claret, F. X. (2017) · Epigenetics · doi:10.1080/15592294.2016.1273308 · Cited by 153
Poly(A) Extensions of miRNAs for Amplification-Free Electrochemical Detection on Screen-Printed Gold Electrodes
Koo, K. M., Carrascosa, L. G., Shiddiky, M. J. A., & Trau, M. (2016) · Analytical Chemistry · doi:10.1021/acs.analchem.5b04795 · Cited by 152
MicroRNA-148a-3p enhances cisplatin cytotoxicity in gastric cancer through mitochondrial fission induction and cyto-protective autophagy suppression
Li, B., Wang, W., Li, Z., Chen, Z., Zhi, X., Xu, J., Li, Q., Wang, L., Huang, X., Wang, L., et al. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.09.035 · Cited by 151
Non-coding RNAs in endometriosis: a narrative review
Panir, K., Schjenken, J. E., Robertson, S. A., & Hull, M. L. (2018) · Human Reproduction Update · doi:10.1093/humupd/dmy014 · Cited by 151
MicroRNA-218 functions as a tumor suppressor in lung cancer by targeting IL-6/STAT3 and negatively correlates with poor prognosis
Yang, Y., Ding, L., Hu, Q., Xia, J., Sun, J., Wang, X., Xiong, H., Gurbani, D., Li, L., Liu, Y., et al. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0710-z · Cited by 150
Editorial focus: understanding off-target effects as the key to successful RNAi therapy
Bartoszewski, R., & Sikorski, A. F. (2019) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-019-0196-3 · Cited by 157
New Insight into microRNA Functions in Cancer: Oncogene–microRNA–Tumor Suppressor Gene Network
Zhou, K., Liu, M., & Cao, Y. (2017) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2017.00046 · Cited by 146
Epigenetic regulation mechanisms of microRNA expression
Morales, S., Monzó, M., & Navarro, A. (2017) · BioMolecular Concepts · doi:10.1515/bmc-2017-0024 · Cited by 159
Nanoarchitecture Frameworks for Electrochemical miRNA Detection
Masud, M. K., Umer, M., Hossain, M. S. A., Yamauchi, Y., Nguyen, N., & Shiddiky, M. J. A. (2019) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2018.11.012 · Cited by 144
microRNA-96 promotes occurrence and progression of colorectal cancer via regulation of the AMPKα2-FTO-m6A/MYC axis
Yue, C., Chen, J., Li, L., Li, L., Chen, J., & Guo, Y.-M. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01731-7 · Cited by 143
The roles of tumor-derived exosomes in non-small cell lung cancer and their clinical implications
Zheng, H., Zhan, Y., Liu, S., Lu, J., Luo, J., Feng, J., & Fan, S. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0901-5 · Cited by 143
LncRNAs with miRNAs in regulation of gastric, liver, and colorectal cancers: updates in recent years
Tam, C., Wong, J. H., Tsui, S. K., Zuo, T., Chan, T., & Ng, T. B. (2019) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-019-09837-5 · Cited by 139
The Untranslated Regions of mRNAs in Cancer
Schuster, S. L., & Hsieh, A. C. (2019) · Trends in cancer · doi:10.1016/j.trecan.2019.02.011 · Cited by 145
Multifaceted role of redox pattern in the tumor immune microenvironment regarding autophagy and apoptosis
Ren, Y., Wang, R., Weng, S., Xu, H., Zhang, Y., Chen, S., Liu, S., Ba, Y., Zhou, Z., Luo, P., et al. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01831-w · Cited by 149
Micrornas in prostate cancer: an overview
Vanacore, D., Boccellino, M., Rossetti, S., Cavaliere, C., D’Aniello, C., Franco, R. D., Romano, F. J., Montanari, M., Mantia, E. L., Piscitelli, R., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.16933 · Cited by 140
Non-invasive prostate cancer detection by measuring miRNA variants (isomiRs) in urine extracellular vesicles
Koppers‐Lalic, D., Hackenberg, M., de Menezes, R., Mišovic, B., Wąchalska, M., Geldof, A. A., Zini, N., de Reijke, T. M., Wurdinger, T. D., Vis, A. N., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8124 · Cited by 135
Post-Transcriptional Regulation of Anti-Apoptotic BCL2 Family Members
Cui, J., & Placzek, W. J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010308 · Cited by 142
Plasmonic Sensors for Extracellular Vesicle Analysis: From Scientific Development to Translational Research
Chin, L. K., Son, T., Hong, J., Liu, A. Q., Skog, J., Castro, C. M., Weissleder, R., Lee, H., & Im, H. (2020) · ACS Nano · doi:10.1021/acsnano.0c07581 · Cited by 135
Emerging landscape of circular RNAs in lung cancer
Hu, W., Bi, Z., Chen, Z., Liu, C., Li, L., Zhang, F., Zhou, Q. Y., Zhu, W., Song, Y., Zhan, B.-T., et al. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.04.006 · Cited by 135
Retracted: Micro RNA ‐34a suppresses the breast cancer stem cell‐like characteristics by downregulating Notch1 pathway
Kang, L., Mao, J., Tao, Y., Song, B., Ma, W., Lü, Y., Zhao, L., Li, J., Yang, B., & Li, L. (2015) · Cancer Science · doi:10.1111/cas.12656 · Cited by 132
Retracted
MicroRNA-155 induction via TNF-α and IFN-γ suppresses expression of programmed death ligand-1 (PD-L1) in human primary cells
Yee, D., Shah, K., Coles, M. C., Sharp, T. V., & Lagos, D. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.809053 · Cited by 137
IGF2BP1 enhances an aggressive tumor cell phenotype by impairing miRNA-directed downregulation of oncogenic factors
Müller, S., Bley, N., Glaß, M., Busch, B., Rousseau, V., Misiak, D., Fuchs, T., Lederer, M., & Hüttelmaier, S. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky229 · Cited by 131
Regulation of antitumor miR‐144‐5p targets oncogenes: Direct regulation of syndecan‐3 and its clinical significance
Yamada, Y., Arai, T., Kojima, S., Sugawara, S., Kato, M., Okato, A., Yamazaki, K., Naya, Y., Ichikawa, T., & Seki, N. (2018) · Cancer Science · doi:10.1111/cas.13722 · Cited by 130
The mini-driver model of polygenic cancer evolution
Castro-Giner, F., Ratcliffe, P. J., & Tomlinson, I. P. M. (2015) · Nature reviews. Cancer · doi:10.1038/nrc3999 · Cited by 133
Cancer Biomarkers Discovery and Validation: State of the Art, Problems and Future Perspectives
Mordente, A., Meucci, E., Martorana, G. E., & Silvestrini, A. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-94-017-7215-0_2 · Cited by 129
Predicting tumor cell line response to drug pairs with deep learning
Xia, F., Shukla, M. P., Brettin, T. S., García–Cardona, C., Cohn, J. D., Allen, J., Maslov, S., Holbeck, S. L., Doroshow, J. H., Evrard, Y. A., et al. (2018) · BMC Bioinformatics · doi:10.1186/s12859-018-2509-3 · Cited by 128

Authors: Hayes, J., Peruzzi, P. P., & Lawler, S.
Affiliations: St James's University Hospital (GB)
The Ohio State University Wexner Medical Center (US)
Brigham and Women's Hospital (US)
Corresponding author: Lawler, Sean
ORCID: Hayes, Josie
Peruzzi, Pier Paolo
Lawler, Sean
Venue: Trends in Molecular Medicine
Publisher: Elsevier BV
Published: 2014-08
Volume: 20
Issue: 8
Pages: 460-469
ISSN: 1471-4914 (ISSN-L)
DOI: 10.1016/j.molmed.2014.06.005
OpenAlex: W1974254202
Cited by: 2,049
References: 79
Citations by year: 2026: 61 · 2025: 78 · 2024: 103 · 2023: 130 · 2022: 186 · 2021: 244 · 2020: 290 · 2019: 273 · 2018: 235 · 2017: 203 · 2016: 140 · 2015: 91 · 2014: 12
FWCI: 14.44
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Trends in Molecular Medicine (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Keywords: microRNA, cancer, biomarkers, microRNA processing, miRNA expression profiling, prognosis, cancer therapy, miRNA mimics, cancer monitoring
MeSH terms: Animals, Humans, Neoplasms, Prognosis, Biomarkers, Tumor, Genetic Therapy, Gene Expression Regulation, Neoplastic, MicroRNAs, Gene Regulatory Networks

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

MicroRNAs in cancer: biomarkers, functions and therapy

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks